Educational Grants

Shionogi Inc. (“Shionogi”) is dedicated to supporting independent Continuing Medical Education (CME) and Continuing Pharmacy Education (CPE) for U.S. healthcare providers working to improve the lives of patients in our therapeutic areas.

Areas of Medical Interest

Shionogi provides independent medical education grants to patient and professional advocacy groups in support of accredited CME and/or CPE in the following areas of medical interest:

Gram-negative multidrug-resistant infectious disease

COVID-19 disease state and management

All grant requests must be unsolicited. Please allow at least 8 weeks for review of any application. 

To apply for grant support, please submit all of the documentation listed below via email to grants.committee@shionogi.com. Grants submitted without the required documentation will not be considered. 

  • A formal letter of request on the entity’s letterhead, signed by an authorized representative.
  • A copy of a detailed agenda, table of contents, detailed protocol(s), educational materials, or a detailed summary of program content, including: 
    • Educational objectives and needs assessment.
    • Description of activity.
    • Outcomes measurement and reporting.
    • Audience generation and activity distribution.
    • Estimated learner participation.
    • Activity timeline.
    • Activity certification (if applicable).
    • Budget with line-item detail.
  • A statement of independence from Shionogi influence, with the grant recipient taking responsibility for selecting content, speakers, faculty, attendees, and logistical elements of the educational program.
  • Documentation of experience in the therapeutic area that may include: details of prior activities, special capabilities of the provider, or educational outcomes of prior activities.
  • The subject line of the submission MUST include the Call for Grant (CFG) ID to be reviewed within the call for grants system. Any submissions that do not list a CFG ID will be reviewed as a spontaneous unsolicited grant request, and decisions on such grants may be delayed.

The detailed description of the educational activity must clearly show: 

  • That the presentation of educational information will be unbiased, balanced, up to date, and scientifically rigorous.
  • How the activity will benefit patient care, knowledge, or other public health objective.

Call for Grants (CFG)

Shionogi allocates the majority of our funding to proposals in response to call for grants posted below.

Shionogi is seeking eligible applicants from Medical Education Providers with experience in executing independent educational programming designed to close knowledge gaps, provide for increased understanding of scientific, clinical, and healthcare issues, and advance patient health outcomes.

Educational Objectives:

The Independent Educational Programming should be focused on:

  1. The current disease landscape and burden of COVID-19
    1. Omicron transmissibility and secondary attack rates
    2. Impact on clinical outcomes and healthcare resource utilization
    3. Risk factors for severe COVID-19 outcomes

    4. Impact of COVID-19 on underlying conditions (e.g. CVD, respiratory, neurological, CKD, etc.)

       

  2. Unmet needs in COVID-19 management
    1. Benefits of preventative early intervention of COVID-19 with oral antivirals
    2. Current treatment uptake in high-risk patients and barriers contributing to low oral antiviral uptake

    3. Importance of SARS-CoV-2 viral titer and viral load reduction, and viral culture; Appropriate time for antiviral treatment based on time of exposure and the viral replication cycle.

       

  3. Post-exposure prophylaxis (PEP) treatment of COVID
    1. Specific populations that could benefit from PEP (e.g. older adults, people with multiple comorbidities, people who live with high-risk patients, individual in long-term care facilities, immunocompromised patients, healthcare workers)
    2. Potential benefits of PEP

    3. Comparative data from randomized, prospective clinical trials on the use of oral antivirals for PEP COVID-19 treatment

       

Activity Type

  • Live and/or virtual/enduring (lasting at least 1 year)
  • Podcast

 

Audience

Primary:

  • Primary Care MDs/DOs
  • Nurses
  • Pharmacists
  • Long-term care facility healthcare providers

Secondary:

  • Infectious Diseases MDs
  • Oncologists
  • Rheumatologists
  • Gerontologists

 

Deadline:

Dec 31, 2026

We are not accepting grants at this time. Please check back as this page is updated periodically.

Amyotrophic Lateral Sclerosis (ALS)

We are currently receiving and reviewing grant funding requests for independent, objective, educational programs and activities that provide legitimate education of healthcare professionals and/or the public in the therapeutic areas of Amyotrophic Lateral Sclerosis (ALS).

Grant requests may come from academic institutions, state or national medical associations or societies, disease foundations and associations, patient associations, or other educational providers. For academic institutions, the University Grants Office should apply for the grant, rather than an individual department or research group. Preference will be given to requests that are ACCME accredited, contain an educational needs assessment, and propose to evaluate post-program educational outcomes.

 

Apply

 

Completed funding requests must be received at least 60 days prior to the program start date.  This allows Shionogi time to review each request thoroughly and answer any questions that applicants might have during the review process.

Once you submit your funding request application, you will receive the following automatic notifications from Shionogi: 

 1. Email notifications indicating that registration has been completed, and application has been submitted for review and has been moved into the triage and review process.

 2. Email notification upon completion of the review process informing of the determination of your application